z-logo
open-access-imgOpen Access
Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community‐Randomized Trial
Author(s) -
Katherine L. O’Brien,
Eugene V. Millar,
Elizabeth R. Zell,
Melinda A. Bronsdon,
Robert Weatherholtz,
Raymond Reid,
Jocelyn Becenti,
Sheri Kvamme,
Cynthia G. Whitney,
Mathuram Santosham
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/521833
Subject(s) - medicine , pneumococcal conjugate vaccine , vaccination , colonization , odds ratio , confidence interval , serotype , pneumococcal infections , randomized controlled trial , vaccine efficacy , immunology , streptococcus pneumoniae , biology , microbiology and biotechnology , antibiotics
Pneumococcal conjugate vaccines (PCVs) prevent vaccine serotype (VT) invasive disease; nonvaccine serotype (NVT) disease increases modestly. The impact of PCV on nasopharyngeal (NP) colonization is essential to understanding disease effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom